Risks of Acetazolamide (Diamox) for Altitude Sickness
Acetazolamide is generally safe for altitude sickness prevention with predominantly mild side effects, but carries rare serious risks including sulfonamide allergic reactions, metabolic acidosis, and idiosyncratic bilateral uveal effusions that can threaten vision.
Common Side Effects
The most frequent adverse effects are mild and dose-related 1:
- Paresthesias (tingling) - particularly in fingers, toes, and perioral region; occurs more frequently at higher doses 2
- Altered taste - particularly metallic taste of carbonated beverages
- Polyuria - increased urination due to mild diuretic effect
- Drowsiness and fatigue - though increasing dose does not increase diuresis and may worsen drowsiness 1
Studies demonstrate that 125 mg twice daily produces similar efficacy to 375 mg twice daily but with significantly less paresthesia (p<0.02) 2. The 62.5 mg twice daily dose is insufficient and should not be used 3.
Serious but Rare Risks
Sulfonamide Hypersensitivity Reactions
As a sulfonamide derivative, acetazolamide can cause 1:
- Anaphylaxis
- Stevens-Johnson syndrome and toxic epidermal necrolysis
- Bone marrow suppression (thrombocytopenic purpura, hemolytic anemia, leukopenia, pancytopenia, agranulocytosis)
- Crystalluria and renal calculi
The FDA label recommends baseline CBC and platelet count before initiating therapy, with periodic monitoring during use 1.
Idiosyncratic Uveal Effusion
A rare but sight-threatening reaction involves bilateral uveal effusions with secondary angle closure 4. This reaction is:
- Independent of dose or prior exposure
- Can occur after a single prophylactic dose
- Presents with acute angle closure and myopic shift within 24 hours
- Requires immediate discontinuation and corticosteroid treatment
Critical caveat: First-time dosing should occur where urgent medical assessment is accessible, not after departure to remote destinations 4.
Metabolic and Electrolyte Disturbances
Acetazolamide causes metabolic acidosis through renal bicarbonate loss 1. Specific risks include:
- Dehydration and electrolyte imbalances - particularly when combined with other diuretics; requires careful evaluation at altitude 5
- Severe toxicity with high-dose aspirin - concomitant use has caused anorexia, tachypnea, lethargy, coma, and death 1
- Periodic monitoring of serum electrolytes is recommended 1
Respiratory Concerns
In patients with pulmonary obstruction or emphysema, acetazolamide may precipitate or aggravate acidosis and should be used with caution 1. However, in controlled trials of COPD patients with moderate to severe disease (FEV1 63% predicted), acetazolamide 375 mg/day significantly reduced altitude-related adverse health effects (49% vs 76% with placebo, NNT=4) without serious adverse events 6.
Cognitive Effects
Acetazolamide impairs neuropsychological function in the first 30 hours after altitude ascent 7. At 6 and 30 hours post-arrival, it worsened:
- Concentration and cognitive processing speed (DSST)
- Reaction time (PASAT)
- Short-term memory and working memory
This cognitive impairment paradoxically occurs despite reducing AMS incidence, creating a clinical dilemma for activities requiring peak mental performance 7.
Drug Interactions and Special Populations
Heart Failure Patients
Concomitant administration of acetazolamide with other diuretics increases dehydration and electrolyte imbalance risk 5. In heart failure patients on ACE inhibitors or ARBs, acetazolamide's effects may be compounded since these medications already blunt erythropoietin production 5.
Pregnancy and Nursing
- Pregnancy Category C: Teratogenic in multiple animal species (limb defects); use only if benefit justifies fetal risk 1
- Contraindicated in nursing mothers due to potential serious adverse reactions in infants 1
Pediatric Use
Safety and effectiveness have not been established in children 1.
Women-Specific Considerations
Women face higher AMS risk and should receive systematic screening 8. Early iron supplementation (6 weeks prior) is recommended for women before altitude exposure, as iron deficiency is more prevalent and adequate stores are needed for hematological adaptation 8. Women may benefit more from combining respiratory muscle training with acetazolamide prophylaxis due to greater expiratory flow limitation 8.
Critical Limitations
Acetazolamide does not obviate the need for prompt descent if severe high-altitude illness occurs 1. It prevents AMS but does not protect against:
- High-altitude pulmonary edema (HAPE)
- High-altitude cerebral edema (HACE)
Gradual ascent remains preferable to pharmacologic prophylaxis alone 1.